E-pharma startups seek more clarity on data privacy

New Delhi: E-pharmacy players on Tuesday said they support the government’s draft e-Pharmacy policy but look forward to more clarity on the data privacy and data management.

Digital health platforms said they are in total support of the draft rules, as it would bring affordability and transparency for consumers, and would oppose the nation-wide strike called by the All India Organisation of Chemists and Druggists (AIOCD) on September 28, 2018.

“Few areas we would like additional clarity on

would be data privacy and data management,” said Prashant Tandon, co-founder, 1mg, on being asked about problems faced by the sector.

The online pharma players were speaking at a media briefing here.

Tandon further said: “There is a parallel Sri Krishna Committee for digital data, which is going on… We would prefer a clarity whether we have to comply with it.

Talking of the recent opposition to the government’s draft policy, the stakeholders said e-pharmacies would empower consumers and provide them multiple options to help them make an informed choice while buying their medicines.

  • Related Posts

    • Pharma
    • April 16, 2024
    • 24 views
    Significant Decline In Pharma Deals In Q1

    NEW DELHI: The pharma and healthcare sector witnessed a significant 15% decline in volume in the first quarter this year, with 47 deals amounting to $ 409 million, as against the…

    • Pharma
    • April 16, 2024
    • 21 views
    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    Ahmedabad: Imagine a bacterial infection with no known cure — a relentless adversary that defies conventional treatments and leads to prolonged illness and hospitalization. This was the condition of nine people…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Significant Decline In Pharma Deals In Q1

    Significant Decline In Pharma Deals In Q1

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    Glenmark recalls 6,528 bottles of BP drug in US

    Glenmark recalls 6,528 bottles of BP drug in US

    Pharma Exports To US Surges 15% In 11 Months Of FY24

    Pharma Exports To US Surges 15% In 11 Months Of FY24

    CAHO Naa Patients Se Pyaar Hai

    CAHO Naa Patients Se Pyaar Hai